https://www.selleckchem.com/pr....oducts/empagliflozin
Changes in metabolism are known to contribute to tumour phenotypes. If and how metabolic alterations in brain tumours contribute to patient outcome is still poorly understood. Epigenetics impact metabolism and mitochondrial function. The aim of this study is a characterisation of metabolic features in molecular subgroups of isocitrate dehydrogenase mutant (IDHmut) and isocitrate dehydrogenase wildtype (IDHwt) gliomas. We employed DNA methylation pattern analyses with a special focus on metabolic genes, large-scale metaboli
Respect!
Kommentar
Delen
